Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/1999
10/14/1999WO1999051748A2 Fusion proteins of mycobacterium tuberculosis antigens and their uses
10/14/1999WO1999051743A1 Humanized antibody against human tissue factor (tf) and process for constructing humanized antibody
10/14/1999WO1999051742A2 Dadd, death activator death domain protein
10/14/1999WO1999051732A1 Secreted proteins and polynucleotides encoding them
10/14/1999WO1999051723A2 Bacterial transglutaminases
10/14/1999WO1999051721A1 Novel recombinant baculovirus, construction method thereof and insect pesticidal composition containing the same
10/14/1999WO1999051642A1 Antibody variants and fragments thereof
10/14/1999WO1999051640A1 Human oxidized ldl receptor
10/14/1999WO1999051639A1 An integrin heterodimer and a subunit thereof
10/14/1999WO1999051632A1 Circularly permuted biotin binding proteins
10/14/1999WO1999051630A1 Lipopeptides inducing t lymphocytic cytotoxicity bearing at least one auxiliary t epitope, and uses for vaccination
10/14/1999WO1999051625A2 Peptides causing formation of compact structures
10/14/1999WO1999051255A1 Telomerase-associated proteins
10/14/1999WO1999042579A3 Caf1-related protein
10/14/1999WO1999040189A3 Cdnas encoding secreted proteins
10/14/1999WO1999039729A3 Use of heregulin as an epithelial cell growth factor
10/14/1999WO1999037660A9 Meth1 and meth2 polynucleotides and polypeptides
10/14/1999WO1999028462A3 Polypeptides and nucleic acids encoding the same
10/14/1999DE19816129A1 T-Zellrezeptor-Expressionskassette T-cell receptor expression cassette
10/14/1999CA2577543A1 Antibody variants and fragments thereof
10/14/1999CA2328294A1 Lipopeptides inducing t lymphocytic cytotoxicity bearing at least one auxiliary t epitope, and uses for vaccination
10/14/1999CA2326598A1 Fusion proteins of mycobacterium tuberculosis antigens and their uses
10/14/1999CA2325571A1 Promoter and constructions for expression of recombinant proteins in filamentous fungi
10/14/1999CA2325346A1 Humanized antibody against human tissue factor (tf) and process for constructing humanized antibody
10/14/1999CA2325339A1 Dadd, death activator death domain protein
10/14/1999CA2325016A1 Hepatitis c virus ns5b compositions and methods of use thereof
10/14/1999CA2324984A1 Secreted proteins and polynucleotides encoding them
10/14/1999CA2324868A1 Human oxidized ldl receptor
10/14/1999CA2324443A1 Expression system for production of proteins
10/14/1999CA2324381A1 An integrin heterodimer and a subunit thereof
10/14/1999CA2324284A1 Peptides causing formation of compact structures
10/14/1999CA2324205A1 Circularly permuted biotin binding proteins
10/13/1999EP0949332A2 HSSCRG1 polypeptides
10/13/1999EP0949271A1 Novel dna, novel protein, and novel antibody
10/13/1999EP0948631A1 Over-expression of proteins
10/13/1999EP0948627A2 Glutathionylspermidine synthetase
10/13/1999EP0948623A2 Isolated mammalian monocyte cell genes; related reagents
10/13/1999EP0948622A1 Human mage-like protein
10/13/1999EP0948621A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions
10/13/1999EP0948617A1 A NOVEL CLONED GABA-RECEPTOR SUBUNIT cDNA SEQUENCE AND STABLY CO-TRANSFECTED CELL LINES
10/13/1999EP0948609A2 Llg polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
10/13/1999EP0948597A1 HUMAN MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MAdCAM-1) AND SPLICE VARIANTS THEREOF
10/13/1999EP0948545A1 Antibodies specifically recognising a nitrosylated protein, method of preparation, therapeutic and diagnostic use
10/13/1999EP0948543A1 Hvem polypeptides and uses thereof
10/13/1999EP0948542A1 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
10/13/1999EP0948540A2 Method for solubilization and naturation of somatotropins
10/13/1999EP0948537A2 Protein binding fragments of gravin
10/13/1999EP0948531A1 Secreted human proteins
10/13/1999EP0948530A2 Mammalian cell surface antigens; related reagents
10/13/1999EP0948528A2 $i(STREPTOCOCCUS UBERIS) LACTOFERRIN-BINDING PROTEIN
10/13/1999EP0948518A1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
10/13/1999EP0948517A1 MAGE-10 ENCODING cDNA, THE TUMOR REJECTION ANTIGEN PRECURSOR MAGE-10, ANTIBODIES SPECIFIC TO THE MOLECULE, AND USES THEREOF
10/13/1999EP0948516A1 Method for determining expression of aberrant forms of apc protein
10/13/1999EP0948515A1 Human b-cell translocation genes-2 and 3
10/13/1999EP0948508A1 Novel coding sequences from herpes simplex virus type-2
10/13/1999EP0948409A1 Apparatus for multi-well microscale synthesis
10/13/1999EP0948348A1 Manipulation of non-terminally differentiated cells using the notch pathway
10/13/1999EP0948323A1 Protease-activated receptor 3 and uses thereof
10/13/1999EP0793502A4 Novel hedgehog-derived polypeptides
10/13/1999EP0770088A4 Novel cytokine designated lerk-5
10/13/1999EP0733121A4 Method of synthesizing a fluorescently labeled protein
10/13/1999EP0618968B1 Tools for the diagnosis and treatment of alzheimer's disease
10/13/1999EP0603307B1 Monoclonal antibodies to putative hcv e2/ns1 proteins and methods for using same
10/13/1999EP0567575B1 Cytokine-induced protein, tsg-6, dna coding therefor and uses thereof
10/13/1999EP0564592B1 Liver enriched transcription factor
10/13/1999EP0555435B1 DNA SEQUENCE ENCODING BOVINE $g(a)-LACTALBUMIN AND METHODS OF USE
10/13/1999CN1231698A DNA-constructs comprising intergenic ribosomal DNA and methods to produce proteins using these DNA-constructs
10/13/1999CN1231697A In vivo protein synthesis method
10/13/1999CN1231695A HBV polyase, RNase H originated from HBV polyase, its preparation process and application in sieving antivirotic agent
10/13/1999CN1231290A High specific acitivity recombined human interferon alpha m and preparation process thereof
10/13/1999CN1045621C Process for preparing immunoglobulin conjugates
10/13/1999CN1045620C Process for preparing DNA construction with preceding sequence of kluyveromyces X-factor directing heterologous polypeptide excretion
10/13/1999CN1045539C CDNA clones coding for polypeptides exhibiting human granulocyte macrophage and eosinophie cellular growth
10/12/1999US5965797 Bacterial genes
10/12/1999US5965794 Viral amplification of recombinant messenger RNA in transgenic plants
10/12/1999US5965725 Polypeptides, and preparation and DNA encoding thereof
10/12/1999US5965724 GP 130 lacking the transmembrane domain
10/12/1999US5965710 An immunoglobulin which binds human membrane-bound carcinoembryonic antigen; anticarcinogenic agent
10/12/1999US5965709 Mutant immunoglobulin e binding determinant sequences in the fc epsilon domain; antiallergens
10/12/1999US5965704 Class two cytokine receptor-11
10/12/1999US5965541 Chimeric adenovirus coat protein of non-native amino acid sequence, which directs entry into cells of a vector more efficiently than a vector which is identical but with a wild-type adenovirus coat protein; ex vivo gene therapy
10/12/1999US5965535 Isolated human leukocyte antigen (hla) class ii-binding peptide and amino sequence encoding it; the peptides stimulate the activity and proliferation of cd4+ t lymphocytes
10/12/1999US5965435 Genetically engineered genes containing the herpes virus of turkeys gc gene, thymidine kinase region of marek's disease virus, infectious laryngotracheitis virus's open reading frame and ribonucleotide reductase genes; for vaccines
10/12/1999US5965430 Bioactive substance having antitumor activity, producing strain, and production thereof
10/12/1999US5965425 Expression of pace in host cells and methods of use thereof
10/12/1999US5965420 A protein which stimulates cell proliferation; treatment of bone loss due to osteoporosis; treat adult respiratory disease syndrome, parkinson'disease, huntington's disease; antiarthritic/anticarcinogenic agents; antiallergens
10/12/1999US5965418 A protein which catalyzes the oxidation of halide ions in the presence of hydrogen peroxide; microbiocides
10/12/1999US5965416 Arginyl tRNA synthetase from staphyloccus aureus
10/12/1999US5965415 Creating hybrid genes by transforming bacteria cells having a defective mismatch repair system or transitorily deactivated with two homologous dna sequences having mismatches, screening cells which have undergone stable recombination
10/12/1999US5965408 Amplifying heterologous, single stranded dna complementary to a gene with random oligonucleotide primers; prematurely terminating synthesis forming variable length strands; denaturing and reannealing strands; repeating cycle
10/12/1999US5965403 Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
10/12/1999US5965392 A nucleic acid molecule; treating obesity or anorexia
10/12/1999US5965391 A structural gene positioned in front of a malate synthase gene which enables controlled expression of desired proteins in corynebacterium by inducing agents added to the medium; genetic engineering
10/12/1999US5965390 Protein L and hybrid proteins thereof
10/12/1999US5965389 Yeast which is transformed with dna construct of regulatory sequences and dna sequence coding glutamate decarboxylase isoform; for high level gene expression and industrial production of enzyme for screening and monitoring of diabetes
10/12/1999US5965388 Isolated polynucleotides; diagnosis and treatment autoimmune diseases, tissue rejection, allergies, acquired immune deficiency disease; viricides, bactericides and fungicides; anticarcinogenic agents
10/12/1999US5965386 Yeast strains and modified albumins
10/12/1999US5965383 Fibrin binding domain polypeptides and uses and methods of producing same
10/12/1999US5965382 Nucleic acid encoding secreted Mac-2 binding glycoprotein
10/12/1999US5965373 Identifying enzyme inhibitors by combining a dimeric protein with a substrate, and a compound believed to be an inhibitor and determining activity of the protein on the substrate; diagnosis of epithelial cancer